Resveratrol modulates MED28 (magicin/EG-1) expression and inhibits epidermal growth factor (EGF)-induced migration in MDA-MB-231 human breast cancer cells

Journal of Agricultural and Food Chemistry

Volumn 59, Issue 21, 2011, Pages 11853-11861

  Lee, Ming Fen ^a   Pan, Min Hsiung ^b   Chiou, Yi Siou ^b   Cheng, An Chin ^a   Huang, Han ^a  

^a CHANG JUNG CHRISTIAN UNIVERSITY   (Taiwan)

^b NATIONAL KAOHSIUNG UNIVERSITY OF APPLIED SCIENCES   (Taiwan)

Author keywords

epidermal growth factor receptor; magicin; matrix metalloproteinase; MDA MB 231; MED28; resveratrol

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTORS; MAGICIN; MATRIX METALLOPROTEINASES; MDA-MB-231; MED28; RESVERATROL;

BIOACTIVITY; CELLS; GENES; MAMMALS; PEPTIDES; TRANSCRIPTION;

DISEASES;

EPIDERMAL GROWTH FACTOR; MED28 PROTEIN, HUMAN; MEDIATOR COMPLEX; PLANT EXTRACT; RESVERATROL; STILBENE DERIVATIVE;

ARTICLE; BREAST TUMOR; CELL MOTION; DOWN REGULATION; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PATHOPHYSIOLOGY; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; DOWN-REGULATION; EPIDERMAL GROWTH FACTOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEDIATOR COMPLEX; PLANT EXTRACTS; STILBENES;

MAMMALIA;

EID: 80455128186     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf202426k     Document Type: Article

References (49)

1. Signorelli, P.; Ghidoni, R. Resveratrol as an anticancer nutrient: molecular basis, open questions and promises J. Nutr. Biochem. 2005, 16, 449-466
2. Rimando, A. M.; Kalt, W.; Magee, J. B.; Dewey, J.; Ballington, J. R. Resveratrol, pterostilbene, and piceatannol in vaccinium berries J. Agric. Food Chem. 2004, 52, 4713-4719
3. Remsberg, C. M.; Yanez, J. A.; Ohgami, Y.; Vega-Villa, K. R.; Rimando, A. M.; Davies, N. M. Pharmacometrics of pterostilbene: preclinical pharmacokinetics and metabolism, anticancer, antiinflammatory, antioxidant and analgesic activity Phytother. Res. 2008, 22, 169-179
4. Dudley, J. I.; Lekli, I.; Mukherjee, S.; Das, M.; Bertelli, A. A.; Das, D. K. Does white wine qualify for French paradox? Comparison of the cardioprotective effects of red and white wines and their constituents: resveratrol, tyrosol, and hydroxytyrosol J. Agric. Food Chem. 2008, 56, 9362-9373
5. Castino, R.; Pucer, A.; Veneroni, R.; Morani, F.; Peracchio, C.; Lah, T. T.; Isidoro, C. Resveratrol reduces the invasive growth and promotes the acquisition of a long-lasting differentiated phenotype in human glioblastoma cells J. Agric. Food Chem. 2011, 59, 4264-4272
6. Alfaras, I.; Juan, M. E.; Planas, J. M. trans-Resveratrol reduces precancerous colonic lesions in dimethylhydrazine-treated rats J. Agric. Food Chem. 2010, 58, 8104-8110
7. Lin, J. N.; Lin, V. C.; Rau, K. M.; Shieh, P. C.; Kuo, D. H.; Shieh, J. C.; Chen, W. J.; Tsai, S. C.; Way, T. D. Resveratrol modulates tumor cell proliferation and protein translation via SIRT1-dependent AMPK activation J. Agric. Food Chem. 2010, 58, 1584-1592
8. Weng, C. J.; Yang, Y. T.; Ho, C. T.; Yen, G. C. Mechanisms of apoptotic effects induced by resveratrol, dibenzoylmethane, and their analogues on human lung carcinoma cells J. Agric. Food Chem. 2009, 57, 5235-5243
9. Lee, S. K.; Zhang, W.; Sanderson, B. J. Selective growth inhibition of human leukemia and human lymphoblastoid cells by resveratrol via cell cycle arrest and apoptosis induction J. Agric. Food Chem. 2008, 56, 7572-7577
10. Juan, M. E.; Wenzel, U.; Daniel, H.; Planas, J. M. Resveratrol induces apoptosis through ROS-dependent mitochondria pathway in HT-29 human colorectal carcinoma cells J. Agric. Food Chem. 2008, 56, 4813-4818
11. Igura, K.; Ohta, T.; Kuroda, Y.; Kaji, K. Resveratrol and quercetin inhibit angiogenesis in vitro Cancer Lett. 2001, 171, 11-16
12. Brakenhielm, E.; Cao, R.; Cao, Y. Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes FASEB J. 2001, 15, 1798-1800
13. Chiou, Y. S.; Tsai, M. L.; Nagabhushanam, K.; Wang, Y. J.; Wu, C. H.; Ho, C. T.; Pan, M. H. Pterostilbene is more potent than resveratrol in preventing azoxymethane (AOM)-induced colon tumorigenesis via activation of the NF-E2-related factor 2 (Nrf2)-mediated antioxidant signaling pathway J. Agric. Food Chem. 2011, 59, 2725-2733
14. Kuo, P. L.; Hsu, Y. L.; Tsai, M. J.; Huang, M. S. Pterostilbene suppresses benzo[a]pyrene-induced airway remodeling J. Agric. Food Chem. 2011, 59, 8028-8035
15. Hynes, N. E.; MacDonald, G. ErbB receptors and signaling pathways in cancer Curr. Opin. Cell Biol. 2009, 21, 177-184
16. Foley, J.; Nickerson, N. K.; Nam, S.; Allen, K. T.; Gilmore, J. L.; Nephew, K. P.; Riese, D. J., 2nd EGFR signaling in breast cancer: Bad to the bone Semin. Cell. Dev. Biol. 2010, 21, 951-960
17. Nicholson, R. I.; Gee, J. M.; Harper, M. E. EGFR and cancer prognosis Eur. J. Cancer 2001, 37 (Suppl. 4) S9-15
18. Salomon, D. S.; Brandt, R.; Ciardiello, F.; Normanno, N. Epidermal growth factor-related peptides and their receptors in human malignancies Crit. Rev. Oncol. Hematol. 1995, 19, 183-232
19. Chrysogelos, S. A.; Dickson, R. B. EGF receptor expression, regulation, and function in breast cancer Breast Cancer Res. Treat. 1994, 29, 29-40
20. Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Murray, T.; Thun, M. J. Cancer statistics, 2008 CA-Cancer J. Clin. 2008, 58, 71-96
21. Browne, B. C.; O'Brien, N.; Duffy, M. J.; Crown, J.; O'Donovan, N. HER-2 signaling and inhibition in breast cancer Curr. Cancer Drug Targets 2009, 9, 419-438
22. Vincenti, M. P.; Brinckerhoff, C. E. Signal transduction and cell-type specific regulation of matrix metalloproteinase gene expression: can MMPs be good for you? J. Cell. Physiol. 2007, 213, 355-364
23. Radisky, E. S.; Radisky, D. C. Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer J. Mammary Gland Biol. Neoplasia 2010, 15, 201-212
24. Mendes, O.; Kim, H. T.; Lungu, G.; Stoica, G. MMP2 role in breast cancer brain metastasis development and its regulation by TIMP2 and ERK1/2 Clin. Exp. Metastasis 2007, 24, 341-351
25. Chabottaux, V.; Noel, A. Breast cancer progression: insights into multifaceted matrix metalloproteinases Clin. Exp. Metastasis 2007, 24, 647-656
26. Wiederhold, T.; Lee, M. F.; James, M.; Neujahr, R.; Smith, N.; Murthy, A.; Hartwig, J.; Gusella, J. F.; Ramesh, V. Magicin, a novel cytoskeletal protein associates with the NF2 tumor suppressor merlin and Grb2 Oncogene 2004, 23, 8815-8825
27. Liu, C.; Zhang, L.; Shao, Z. M.; Beatty, P.; Sartippour, M.; Lane, T. F.; Barsky, S. H.; Livingston, E.; Nguyen, M. Identification of a novel endothelial-derived gene EG-1 Biochem. Biophys. Res. Commun. 2002, 290, 602-612
28. Sato, S.; Tomomori-Sato, C.; Parmely, T. J.; Florens, L.; Zybailov, B.; Swanson, S. K.; Banks, C. A.; Jin, J.; Cai, Y.; Washburn, M. P.; Conaway, J. W.; Conaway, R. C. A set of consensus mammalian mediator subunits identified by multidimensional protein identification technology Mol. Cell 2004, 14, 685-691
29. Lu, M.; Zhang, L.; Maul, R. S.; Sartippour, M. R.; Norris, A.; Whitelegge, J.; Rao, J. Y.; Brooks, M. N. The novel gene EG-1 stimulates cellular proliferation Cancer Res. 2005, 65, 6159-6166
30. Lu, M.; Sartippour, M. R.; Zhang, L.; Norris, A. J.; Brooks, M. N. Targeted inhibition of EG-1 blocks breast tumor growth Cancer Biol. Ther. 2007, 6, 936-941
31. Zhang, L.; Maul, R. S.; Rao, J.; Apple, S.; Seligson, D.; Sartippour, M.; Rubio, R.; Brooks, M. N. Expression pattern of the novel gene EG-1 in cancer Clin. Cancer Res. 2004, 10, 3504-3508
32. Yoon, N. K.; Maresh, E. L.; Elshimali, Y.; Li, A.; Horvath, S.; Seligson, D. B.; Chia, D.; Goodglick, L. Elevated MED28 expression predicts poor outcome in women with breast cancer BMC Cancer 2010, 10, 335
33. Lu, M.; Zhang, L.; Sartippour, M. R.; Norris, A. J.; Brooks, M. N. EG-1 interacts with c-Src and activates its signaling pathway Int. J. Oncol. 2006, 29, 1013-1018
34. Lee, M. F.; Beauchamp, R. L.; Beyer, K. S.; Gusella, J. F.; Ramesh, V. Magicin associates with the Src-family kinases and is phosphorylated upon CD3 stimulation Biochem. Biophys. Res. Commun. 2006, 348, 826-831
35. Wheeler, D. L.; Iida, M.; Dunn, E. F. The role of Src in solid tumors Oncologist 2009, 14, 667-678
36. Biscardi, J. S.; Ishizawar, R. C.; Silva, C. M.; Parsons, S. J. Tyrosine kinase signalling in breast cancer: epidermal growth factor receptor and c-Src interactions in breast cancer Breast Cancer Res. 2000, 2, 203-210
37. Lu, J.; Ho, C. H.; Ghai, G.; Chen, K. Y. Resveratrol analog, 3,4,5,4′-tetrahydroxystilbene, differentially induces pro-apoptotic p53/Bax gene expression and inhibits the growth of transformed cells but not their normal counterparts Carcinogenesis 2001, 22, 321-328
38. Pan, M. H.; Chiou, Y. S.; Chen, W. J.; Wang, J. M.; Badmaev, V.; Ho, C. T. Pterostilbene inhibited tumor invasion via suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells Carcinogenesis 2009, 30, 1234-1242
39. Beyer, K. S.; Beauchamp, R. L.; Lee, M. F.; Gusella, J. F.; Naar, A. M.; Ramesh, V. Mediator subunit MED28 (Magicin) is a repressor of smooth muscle cell differentiation J. Biol. Chem. 2007, 282, 32152-32157
40. Azios, N. G.; Dharmawardhane, S. F. Resveratrol and estradiol exert disparate effects on cell migration, cell surface actin structures, and focal adhesion assembly in MDA-MB-231 human breast cancer cells Neoplasia 2005, 7, 128-140
41. Yan, C.; Boyd, D. D. Regulation of matrix metalloproteinase gene expression J. Cell. Physiol. 2007, 211, 19-26
42. Hollborn, M.; Stathopoulos, C.; Steffen, A.; Wiedemann, P.; Kohen, L.; Bringmann, A. Positive feedback regulation between MMP-9 and VEGF in human RPE cells Invest. Ophthalmol. Vis. Sci. 2007, 48, 4360-4367
43. Nee, L.; Tuite, N.; Ryan, M. P.; McMorrow, T. TNF-alpha and IL-1 beta-mediated regulation of MMP-9 and TIMP-1 in human glomerular mesangial cells Nephron Exp. Nephrol. 2007, 107, e73-86
44. Alkhalaf, M. Resveratrol-induced growth inhibition in MDA-MB-231 breast cancer cells is associated with mitogen-activated protein kinase signaling and protein translation Eur. J. Cancer Prev. 2007, 16, 334-341
45. Tang, F. Y.; Chiang, E. P.; Sun, Y. C. Resveratrol inhibits heregulin-beta1-mediated matrix metalloproteinase-9 expression and cell invasion in human breast cancer cells J. Nutr. Biochem. 2008, 19, 287-294
46. Azios, N. G.; Krishnamoorthy, L.; Harris, M.; Cubano, L. A.; Cammer, M.; Dharmawardhane, S. F. Estrogen and resveratrol regulate Rac and Cdc42 signaling to the actin cytoskeleton of metastatic breast cancer cells Neoplasia 2007, 9, 147-158
47. Da Silva, L.; Clarke, C.; Lakhani, S. R. Demystifying basal-like breast carcinomas J. Clin. Pathol. 2007, 60, 1328-1332
48. Burness, M. L.; Grushko, T. A.; Olopade, O. I. Epidermal growth factor receptor in triple-negative and basal-like breast cancer: promising clinical target or only a marker? Cancer J. 16, 23-32.
49. Freudenberg, J. A.; Wang, Q.; Katsumata, M.; Drebin, J.; Nagatomo, I.; Greene, M. I. The role of HER2 in early breast cancer metastasis and the origins of resistance to HER2-targeted therapies Exp. Mol. Pathol. 2009, 87, 1-11